| 1 |
Ezhilarasan D. Unraveling the pathophysiologic role of galectin-3 in chronically injured liver. J Cell Physiol 2023. [PMID: 36745560 DOI: 10.1002/jcp.30956] [Reference Citation Analysis]
|
| 2 |
Pedrosa LF, Fabi JP. Dietary fiber as a wide pillar of colorectal cancer prevention and adjuvant therapy. Crit Rev Food Sci Nutr 2023;:1-21. [PMID: 36606552 DOI: 10.1080/10408398.2022.2164245] [Reference Citation Analysis]
|
| 3 |
Zhao N, Chen C, Guo Y, Liu T, Che N, Zhang D, Liang X, Zhang Y, Zhao X. LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry. Dig Liver Dis 2022:S1590-8658(22)00695-8. [PMID: 36192339 DOI: 10.1016/j.dld.2022.09.003] [Reference Citation Analysis]
|
| 4 |
Pulica R, Cohen-solal K, Lasfar A. Evaluating the Role of RUNX2 in Cancer and Its Potential as a Therapeutic Target. Handbook of Cancer and Immunology 2022. [DOI: 10.1007/978-3-030-80962-1_254-1] [Reference Citation Analysis]
|
| 5 |
Zhang J, Li H, Dong J, Zhang N, Liu Y, Luo X, Chen J, Wang J, Wang A. Omics-Based Identification of Shared and Gender Disparity Routes in Hras12V-Induced Hepatocarcinogenesis: An Important Role for Dlk1-Dio3 Genomic Imprinting Region. Front Genet 2021;12:620594. [PMID: 34135934 DOI: 10.3389/fgene.2021.620594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Wu CY, Li L, Chen SL, Yang X, Zhang CZ, Cao Y. A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma. Cell Death Dis 2021;12:319. [PMID: 33767130 DOI: 10.1038/s41419-021-03617-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Zheng N, Zhang S, Wu W, Zhang N, Wang J. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma. Pharmacol Res 2021;166:105507. [PMID: 33610718 DOI: 10.1016/j.phrs.2021.105507] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 8 |
Jing GY, Zheng XZ, Ji XX. lncRNA HAND2-AS1 overexpression inhibits cancer cell proliferation in hepatocellular carcinoma by downregulating RUNX2 expression. J Clin Lab Anal 2021;35:e23717. [PMID: 33566427 DOI: 10.1002/jcla.23717] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Liu B, Pan S, Liu J, Kong C. Cancer-associated fibroblasts and the related Runt-related transcription factor 2 (RUNX2) promote bladder cancer progression. Gene 2021;775:145451. [PMID: 33482279 DOI: 10.1016/j.gene.2021.145451] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 10 |
Cao Z, Sun B, Zhao X, Zhang Y, Gu Q, Liang X, Dong X, Zhao N. Correction: Cao, Z., et al. The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition. Int. J. Mol. Sci. 2017, 18, 500. Int J Mol Sci 2020;22:E77. [PMID: 33374891 DOI: 10.3390/ijms22010077] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 11 |
Cheng R, Wang B, Cai XR, Chen ZS, Du Q, Zhou LY, Ye JM, Chen YL. CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway. Onco Targets Ther 2020;13:11485-98. [PMID: 33204103 DOI: 10.2147/OTT.S271891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 12 |
Steensels S, Qiao J, Ersoy BA. Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease. Metabolites 2020;10:E283. [PMID: 32660130 DOI: 10.3390/metabo10070283] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 13 |
Han C, Jin L, Ma X, Hao Q, Lin H, Zhang Z. Identification of the hub genes RUNX2 and FN1 in gastric cancer. Open Med (Wars) 2020;15:403-12. [PMID: 33313404 DOI: 10.1515/med-2020-0405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 14 |
Fathi Maroufi N, Taefehshokr S, Rashidi MR, Taefehshokr N, Khoshakhlagh M, Isazadeh A, Mokarizadeh N, Baradaran B, Nouri M. Vascular mimicry: changing the therapeutic paradigms in cancer. Mol Biol Rep 2020;47:4749-65. [PMID: 32424524 DOI: 10.1007/s11033-020-05515-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 15 |
Fritz AJ, Hong D, Boyd J, Kost J, Finstaad KH, Fitzgerald MP, Hanna S, Abuarqoub AH, Malik M, Bushweller J, Tye C, Ghule P, Gordon J, Frietze S, Zaidi SK, Lian JB, Stein JL, Stein GS. RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells. J Cell Physiol 2020;235:7261-72. [PMID: 32180230 DOI: 10.1002/jcp.29625] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 16 |
Hernández de la Cruz ON, López-González JS, García-Vázquez R, Salinas-Vera YM, Muñiz-Lino MA, Aguilar-Cazares D, López-Camarillo C, Carlos-Reyes Á. Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors. Front Oncol 2019;9:1419. [PMID: 31993365 DOI: 10.3389/fonc.2019.01419] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 17 |
Bolf EL, Gillis NE, Barnum MS, Beaudet CM, Yu GY, Tomczak JA, Stein JL, Lian JB, Stein GS, Carr FE. The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer. Horm Cancer 2020;11:34-41. [PMID: 31865591 DOI: 10.1007/s12672-019-00373-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Lee CH. Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids. Cancers (Basel) 2019;11:E1841. [PMID: 31766574 DOI: 10.3390/cancers11121841] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 19 |
Zhong L, Huang L, Xue Q, Liu C, Xu K, Shen W, Deng L. Cell-specific elevation of Runx2 promotes hepatic infiltration of macrophages by upregulating MCP-1 in high-fat diet-induced mice NAFLD. J Cell Biochem 2019;120:11761-74. [PMID: 30746746 DOI: 10.1002/jcb.28456] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 20 |
Cecconi D, Brandi J, Manfredi M, Serena M, Dalle Carbonare L, Deiana M, Cheri S, Parolini F, Gandini A, Marchetto G, Innamorati G, Avanzi F, Antoniazzi F, Marengo E, Tiso N, Mottes M, Zipeto D, Valenti MT. Runx2 stimulates neoangiogenesis through the Runt domain in melanoma. Sci Rep 2019;9:8052. [PMID: 31142788 DOI: 10.1038/s41598-019-44552-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 21 |
Chen Q, Lin W, Yin Z, Zou Y, Liang S, Ruan S, Chen P, Li S, Shu Q, Cheng B, Ling C. Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1α/Akt Pathway in Liver Cancer. Evid Based Complement Alternat Med 2019;2019:9602935. [PMID: 31057657 DOI: 10.1155/2019/9602935] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 22 |
Liu J, Ke F, Cheng H, Zhou J. Traditional Chinese medicine as targeted treatment for epithelial-mesenchymal transition-induced cancer progression. J Cell Biochem 2019;120:1068-79. [PMID: 30431663 DOI: 10.1002/jcb.27588] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 23 |
Nangia-Makker P, Hogan V, Raz A. Galectin-3 and cancer stemness. Glycobiology. 2018;28:172-181. [PMID: 29315388 DOI: 10.1093/glycob/cwy001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 24 |
Meng J, Chen S, Lei YY, Han JX, Zhong WL, Wang XR, Liu YR, Gao WF, Zhang Q, Tan Q, Liu HJ, Zhou HG, Sun T, Yang C. Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma. Oncogene 2019;38:228-43. [PMID: 30087438 DOI: 10.1038/s41388-018-0428-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 25 |
Liu F, Zhang J, Qian J, Wu G, Ma Z. Emodin alleviates CCl4‑induced liver fibrosis by suppressing epithelial‑mesenchymal transition and transforming growth factor‑β1 in rats. Mol Med Rep 2018;18:3262-70. [PMID: 30066878 DOI: 10.3892/mmr.2018.9324] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 26 |
Huang H, Liu Y, Yu P, Qu J, Guo Y, Li W, Wang S, Zhang J. MiR-23a transcriptional activated by Runx2 increases metastatic potential of mouse hepatoma cell via directly targeting Mgat3. Sci Rep 2018;8:7366. [PMID: 29743543 DOI: 10.1038/s41598-018-25768-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 27 |
Li B, Mao X, Wang H, Su G, Mo C, Cao K, Qiu S. Vasculogenic mimicry in bladder cancer and its association with the aberrant expression of ZEB1. Oncol Lett 2018;15:5193-200. [PMID: 29552157 DOI: 10.3892/ol.2018.7975] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 28 |
Yang LV. Tumor Microenvironment and Metabolism. Int J Mol Sci 2017;18:E2729. [PMID: 29258182 DOI: 10.3390/ijms18122729] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 29 |
Cheng R, Cai XR, Ke K, Chen YL. Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells. J Huazhong Univ Sci Technolog Med Sci 2017;37:719-25. [PMID: 29058285 DOI: 10.1007/s11596-017-1794-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 30 |
Zhang P, Sun H, Yang B, Luo W, Liu Z, Wang J, Zuo Y. miR-152 regulated glioma cell proliferation and apoptosis via Runx2 mediated by DNMT1. Biomed Pharmacother 2017;92:690-5. [PMID: 28595085 DOI: 10.1016/j.biopha.2017.05.096] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 31 |
Delgado-Bellido D, Serrano-Saenz S, Fernández-Cortés M, Oliver FJ. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Mol Cancer 2017;16:65. [PMID: 28320399 DOI: 10.1186/s12943-017-0631-x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 115] [Article Influence: 17.7] [Reference Citation Analysis]
|
